What is the Zuspan regimen for administering magnesium sulfate in eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Zuspan Regimen for Magnesium Sulfate Administration

The Zuspan regimen consists of a 4 g IV loading dose of magnesium sulfate given over 3-4 minutes, followed by a continuous IV infusion of 1-2 g/hour (most commonly 1 g/hour) for maintenance, continued for 24 hours postpartum. 1

Loading Dose

  • 4 g magnesium sulfate IV administered over 3-4 minutes
  • Dilute the 50% solution to a 10% or 20% concentration before IV administration
    • 40 mL of 10% solution OR 20 mL of 20% solution
  • Provides therapeutic levels almost immediately 1

Maintenance Dose

  • 1-2 g/hour by continuous IV infusion using a controlled infusion pump 1
  • The 1 g/hour maintenance dose is as effective as 2 g/hour for eclampsia prevention with significantly fewer maternal side effects (22% vs 67-71%) 2
  • Continue until seizures cease or for 24 hours postpartum 3

Key Differences from Pritchard Regimen

The Zuspan regimen is entirely intravenous, whereas the Pritchard regimen combines IV and intramuscular routes. The Zuspan approach avoids painful IM injections and provides more consistent serum levels through continuous infusion 4, 5.

Therapeutic Monitoring

Essential safety parameters:

  • Patellar reflexes - Loss occurs at 3.5-5 mmol/L (first sign of toxicity) 5
  • Respiratory rate - Must remain >12-16 breaths/minute; respiratory paralysis occurs at 5-6.5 mmol/L 5
  • Urine output - Maintain >25-30 mL/hour (magnesium is renally excreted) 1
  • Target serum magnesium - 1.8-3.0 mmol/L (therapeutic range); 6 mg/100 mL optimal for seizure control 1, 5

Critical Safety Considerations

Maximum dosing limits:

  • Total daily dose should not exceed 30-40 g in 24 hours 1
  • In severe renal insufficiency, maximum is 20 g/48 hours with frequent serum level monitoring 1
  • Never continue beyond 5-7 days - prolonged use causes fetal abnormalities 1

Toxicity progression:

  • 3.5-5 mmol/L: Loss of deep tendon reflexes
  • 5-6.5 mmol/L: Respiratory depression/paralysis
  • 7.5 mmol/L: Cardiac conduction abnormalities

  • 12.5 mmol/L: Cardiac arrest 5

Antidote: Have calcium gluconate 1 g (10 mL of 10% solution) IV immediately available for reversal of magnesium toxicity 1

Guideline Endorsement

The ISSHP 2018 guidelines explicitly recommend using "the dosing regimens used in the Eclampsia and MAGPIE trials" - which includes the Zuspan regimen - and emphasize that each unit should have a consistent MgSO4 protocol with appropriate monitoring 3. The FDA labeling confirms this as standard dosing for severe preeclampsia and eclampsia 1.

Common Pitfalls

  • Avoid fluid overload: Limit total IV fluids to 60-80 mL/hour during magnesium infusion to prevent pulmonary edema in preeclamptic patients with capillary leak 3
  • Drug interactions: Magnesium potentiates neuromuscular blockade and can cause excessive hypotension when combined with nifedipine or other calcium channel blockers 6, 1
  • Renal function: Always assess baseline renal function; adjust dosing and increase monitoring frequency in renal insufficiency 1

Related Questions

How should I maintain a magnesium sulfate infusion at 1 gram per hour using a Soluset pump and document the order on the medication chart?
What is the recommended use of magnesium sulfate for seizure prophylaxis and treatment in pre‑eclampsia and eclampsia?
What are the recommended magnesium sulfate dosing regimens for its most common indications in adults (severe pre‑eclampsia/eclampsia, torsades de pointes, acute severe asthma, hypomagnesemia) and in children?
Before administering magnesium sulfate, which baseline laboratory and clinical assessments should be obtained to prevent toxicity?
What are the recommended magnesium sulfate (MgSO₄) dosing regimens for adults, pregnant patients with severe pre‑eclampsia/eclampsia, torsades de pointes, and children?
What bowel preparation regimen should be used before a transrectal ultrasound‑guided (TRUS) prostate biopsy?
What are the first‑line pharmacologic treatments for acute bronchitis and acute bacterial sinusitis in otherwise healthy adults?
When should meropenem be used for typhoid fever and what is the appropriate dosing regimen?
What is the recommended apixaban dose for deep vein thrombosis prophylaxis after major orthopedic surgery (hip or knee replacement) and in medically ill patients?
Why has the World Health Organization not commented on the CDC's recommendation to extend oral artemisinin-based combination therapy to five days for uncomplicated malaria?
Which medications can be given to a patient with vertigo and how many rest days should be indicated on a medical certificate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.